SUSAN FAJARDO: Open Payments
NPI 1073522447 · SHAWNEE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 47 payments from 11 companies in 2025. Trend: 2023 $1,258 · 2024 $1,185 · 2025 $1,555
Food & beverage: $1,555
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $354 |
| AstraZeneca Pharmaceuticals LP | 7 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $189 |
| Novo Nordisk Inc | 5 | $168 |
| Amgen Inc. | 8 | $167 |
| GlaxoSmithKline, LLC. | 1 | $97 |
| Lilly USA, LLC | 4 | $75 |
| Medtronic, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: FARXIGA, ZAVZPRET, CAPLYTA, XIFAXAN, NURTEC ODT, Ozempic, REPATHA, PENMENVY.
Industry payments across KS — which companies pay providers there.
